Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2014 by VentiRx Pharmaceuticals Inc.
Sponsor:
Information provided by (Responsible Party):
VentiRx Pharmaceuticals Inc.
ClinicalTrials.gov Identifier:
NCT01836029
First received: April 12, 2013
Last updated: August 14, 2014
Last verified: August 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2015
  Estimated Primary Completion Date: September 2015 (Final data collection date for primary outcome measure)
No publications provided by VentiRx Pharmaceuticals Inc.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):